Advertisement

Long-term prognostic value of coronary flow reserve in psoriasis patients

      Highlights

      • This study analyzed the prognostic role of coronary flow reserve in psoriasis.
      • 153 psoriatic patients without cardiovascular disease were included.
      • Coronary microvascular dysfunction was present in 15% of patients.
      • Coronary flow reserve may be a prognostic marker for events-free survival.

      Abstract

      Background and aims

      Psoriasis affects more than 3% of the general population and is associated with an increased risk of premature cardiovascular events and death. We assessed the prognostic role of coronary flow reserve (CFR) as a marker of coronary microvascular function in psoriasis patients asymptomatic for cardiovascular disease.

      Methods

      We retrospectively analyzed 153 prospectively collected patients affected by psoriasis (123 male; age 36 ± 8 years) without cardiovascular disease. CFR in the left anterior descending coronary artery was detected by transthoracic Doppler echocardiography, at rest, and during adenosine infusion. CFR was the ratio of hyperemic to resting diastolic flow velocity. CFR ≤2.5 was the cut off to define the presence of coronary microvascular dysfunction (CMD).

      Results

      CMD was present in 23 patients (15%). Multivariable logistic regression analysis showed that CMD was associated with severe psoriasis (OR 3.1, p = 0.03), psoriatic arthritis (OR 2.9, p = 0.03), hypertension (OR 4.1, p = 0.009), and time elapsing since psoriasis diagnosis >6 years (OR 1.9, p = 0.03). Patients with CFR ≤2.5 had a lower survival free from events (p < 0.0001).

      Conclusions

      In psoriasis patients, CFR may be a reliable prognostic marker for cardiovascular event-free survival and may help identify patients at higher risk of developing cardiovascular complications. Whether novel biologic therapies able to reduce skin disease will improve CMD and prognosis in these patients needs to be further studied, prospectively.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Faccini A.
        • Kaski J.C.
        • Camici P.G.
        Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases.
        Eur. Heart J. 2016; 37: 1799-1806
        • Gelfand J.M.
        • Neimann A.L.
        • Shin D.B.
        • Wang X.
        • Margolis D.J.
        • et al.
        Risk of myocardial infarction in patients with psoriasis.
        J. Am. Med. Assoc. 2006; 296: 1735-1741
        • Lerman J.B.
        • Joshi A.A.
        • Chaturvedi A.
        • Aberra T.M.
        • Dey A.K.
        • et al.
        Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study.
        Circulation. 2017; 136: 263-276
        • Ridker P.M.
        • Everett B.M.
        • Thuren T.
        • MacFadyen J.G.
        • Chang W.H.
        • et al.
        CANTOS trial group. Antiinflammatory therapy with Canakinumab for atherosclerotic disease.
        N. Engl. J. Med. 2017; 377: 1119-1131
        • Elnabawi Y.A.
        • Dey A.K.
        • Goyal A.
        • Groenendyk J.W.
        • Chung J.H.
        • et al.
        Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study.
        Cardiovasc. Res. 2019; 115: 721-728
        • Wu J.J.
        • Poon K.-Y.T.
        • Channual J.C.
        • Shen A.Y.-J.
        Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis.
        Arch. Dermatol. 2012; 148: 1244-1250
        • Camici P.G.
        • Crea F.
        Coronary microvascular dysfunction.
        N. Engl. J. Med. 2007; 356: 830-840
        • Osto E.
        • Piaserico S.
        • Maddalozzo A.
        • Forchetti G.
        • Montisci R.
        • et al.
        Impaired coronary flow reserve in young patients affected by severe psoriasis.
        Atherosclerosis. 2012; 221: 113-117
        • Piaserico S.
        • Osto E.
        • Famoso G.
        • Zanetti I.
        • Gregori D.
        • et al.
        Treatment with tumor necrosis factor inhibitors restores coronary microvascular function in young patients with severe psoriasis.
        Atherosclerosis. 2016; 251: 25-30
        • Vacca A.
        • Montisci R.
        • Garau P.
        • Siotto P.
        • Piga M.
        • et al.
        Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of noninvasive tests.
        Arthritis Res. Ther. 2013; 15: R8
        • Devereux R.B.
        • Alonso D.R.
        • Lutas E.M.
        • Gottlieb G.J.
        • Campo E.
        • et al.
        Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.
        Am. J. Cardiol. 1986; 57: 450-458
        • Nagueh S.F.
        • Appleton C.P.
        • Gillebert T.C.
        • Marino P.N.
        • Oh J.K.
        • et al.
        Recommendations for the evaluation of left ventricular diastolic function by echocardiography.
        J. Am. Soc. Echocardiogr. 2009; 22: 107-133
        • Redfield M.M.
        • Jacobsen S.J.
        • Burnett Jr., J.C.
        • Mahoney D.W.
        • Balley K.R.
        • et al.
        Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.
        J. Am. Med. Assoc. 2003; 289: 194-202
        • Tona F.
        • Caforio A.L.P.
        • Montisci R.
        • Gambino A.
        • Angelini A.
        • et al.
        Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation.
        Circulation. 2006; 114 (I-49–55)
        • Rubinshtein R.
        • Yang E.H.
        • Rihal C.S.
        • Prasad A.
        • Lennon R.J.
        • et al.
        Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score.
        Eur. Heart J. 2009; 31: 936-942
        • Russo V.
        • Zavalloni A.
        • Bacci Reggiani M.L.
        • Buttazzi K.
        • Gostoli V.
        • et al.
        Incremental prognostic value of coronary CT angiography in patients with suspected coronary artery disease.
        Circ. Cardiovasc. Imaging. 2010; 3: 351-359
        • Thygesen K.
        • Alpert J.S.
        • Jaffe A.S.
        • Chaitman B.R.
        • Bax J.J.
        • et al.
        Executive group on behalf of the joint european society of cardiology (ESC)/American college of cardiology (ACC)/American heart association (AHA)/World heart federation (WHF) task force for the universal definition of myocardial infarction.
        J. Am. Coll. Cardiol. 2018; 18: 2231-2264
        • Roffi M.
        • Patrono C.
        • Collet J.P.
        • Mueller C.
        • Valgimigli M.
        • ESC Scientific Document Group
        • et al.
        2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the european society of cardiology (ESC).
        Eur. Heart J. 2016; 37: 267-315
        • Tamis-Holland J.E.
        • Jneid H.
        Myocardial Infarction with nonobstructive coronary arteries (MINOCA): it's time to face reality!.
        J. Am. Heart. Assoc. 2018; 7 (pii: e009635)
        • Mehta N.N.
        • Azfar R.S.
        • Shin D.B.
        • Neimann A.L.
        • Troxel A.B.
        • et al.
        Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the general practice research database.
        Eur. Heart J. 2010; 31: 1000-1006
        • Gelfand J.M.
        • Troxel A.B.
        • Lewis J.D.
        • Kurd S.K.
        • Shin D.B.
        • et al.
        The risk of mortality in patients with psoriasis: results from a population-based study.
        Arch. Dermatol. 2007; 143: 1493-1499
        • Brauchli Y.B.
        • Jick S.S.
        • Miret M.
        • Meier C.R.
        Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis.
        Br. J. Dermatol. 2009; 160: 1048-1056
        • Mehta N.N.
        • Yu Y.
        • Pinnelas R.
        • Krishnamoorthy P.
        • Shin D.B.
        • et al.
        Attributable risk estimate of severe psoriasis on major cardiovascular events.
        Am. J. Med. 2011; 124: 775e1-775e6
        • Sicari R.
        • Rigo F.
        • Cortigiani L.
        • Gherardi S.
        • Galderisi M.
        • et al.
        Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries.
        Am. J. Cardiol. 2009; 103: 626-631
        • Nakanishi K.
        • Fukuda S.
        • Shimada K.
        • Miyazaki C.
        • Otsuka K.
        • et al.
        Impaired coronary flow reserve as a marker of microvascular dysfunction to predict long-term cardiovascular outcomes, acute coronary syndrome and the development of heart failure.
        Circ. J. 2012; 76: 1958-1964
        • Cortigiani L.
        • Rigo F.
        • Gherardi S.
        • Galderisi M.
        • Bovenzi F.
        • et al.
        Prognostic meaning of coronary microvascular disease in type 2 diabetes mellitus: a transthoracic Doppler echocardiographic study.
        J. Am. Soc. Echocardiogr. 2014; 27: 742-748
        • Kawata T.
        • Daimon M.
        • Hasegawa R.
        • Toyoda T.
        • Sekine T.
        • et al.
        Prognostic value of coronary flow reserve assessed by transthoracic Doppler echocardiography on long-term outcome in asymptomatic patients with type 2 diabetes without overt coronary artery disease.
        Cardiovasc. Diabetol. 2013; 12: 121-128
        • Arroyo-Espliguero R.
        • Mollichelli N.
        • Avanzas P.
        • Zouridakis E.
        • Newey V.R.
        • et al.
        Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X.
        Eur. Heart J. 2003; 24: 2006-2011
        • Caliskan M.
        • Erdogan D.
        • Gullu H.
        • Yilmaz S.
        • Gursoy Y.
        • et al.
        Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis.
        Atherosclerosis. 2008; 196: 306-312
        • Recio-Mayoral A.
        • Mason J.C.
        • Kaski J.C.
        • Rubens M.B.
        • Harari O.A.
        • et al.
        Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease.
        Eur. Heart J. 2009; 30: 1837-1843
        • Kaufmann P.A.
        • Gnecchi-Ruscone T.
        • Di T.M.
        • Schafers K.P.
        • Luscher T.F.
        • et al.
        Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function.
        Circulation. 2000; 102: 1233-1238
        • Asahina A.
        • Umezawa Y.
        • Yanaba K.
        • Nakagawa H.
        Serum C-reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: long-term differential effects of biologics.
        J. Dermatol. 2016 Jul; 43: 779-784
        • Snekvik I.
        • Nilsen T.I.L.
        • Romundstad P.R.
        • Saunes M.
        Psoriasis and cardiovascular disease risk factors: the HUNT Study, Norway.
        J. Eur. Acad. Dermatol. Venereol. 2018 May; 32: 776-782
        • Zhang H.
        • Park Y.
        • Wu J.
        • Chen Xp
        • Lee S.
        • et al.
        Role of TNF-alpha in vascular dysfunction.
        Clin. Sci. 2009; 116: 219-230
        • Woodward M.
        • Welsh P.
        • Rumley A.
        • Tunstall-Pedoe H.
        • Lowe G.D.
        Do inflammatory biomarkers add to the discrimination of cardiovascular disease after allowing for social deprivation? Results from a 10-year cohort study in Glasgow, Scotland.
        Eur. Heart J. 2010 Nov; 31: 2669-2675
        • Kaptoge S.
        • Seshasai S.R.
        • Gao P.
        • Freitag D.F.
        • Butterworth A.S.
        • et al.
        Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis.
        Eur. Heart J. 2014 Mar; 35: 578-589
        • Beringer A.
        • Noack M.
        • Miossec P.
        IL-17 in Chronic Inflammation: from discovery to targeting.
        Trends Mol. Med. 2016; 22: 230-241
        • Puig L.
        Cardiometabolic comorbidities in psoriasis and psoriatic arthritis.
        Int. J. Mol. Sci. 2017; 25: 58-74
        • Minihane A.M.
        • Vinoy S.
        • Russell W.R.
        • Baka A.
        • Roche H.M.
        • et al.
        Low-grade inflammation, diet composition and health: current research evidence and its translation.
        Br. J. Nutr. 2015; 114: 999-1012
        • Molina-Leyva A.
        • Cuenca-Barrales C.
        • Vega-Castillo J.J.
        • Ruiz-Carrascosa J.C.
        • Ruiz-Villaverde R.
        Adherence to mediterranean diet in Spanish patients with psoriasis: cardiovascular benefits?.
        Dermatol. Ther. 2019; 32e12810
        • Phan C.
        • Touvier M.
        • Kesse-Guyot E.
        • Adjibade M.
        • Hercberg S.
        • et al.
        Association between mediterranean anti-inflammatory dietary profile and severity of psoriasis: results from the NutriNet-Santé Cohort.
        JAMA Dermatol. 2018; 154: 1017-1024